Vaccine therapy for choroidal neovascularization

Details for Australian Patent Application No. 2008215432 (hide)

Owner Oncotherapy Science, Inc.

Inventors Tahara, Hideaki; Tamaki, Yasuhiro

Agent Davies Collison Cave

Pub. Number AU-A-2008215432

PCT Pub. Number WO2008/099908

Priority 2007-036318 16.02.07 JP

Filing date 15 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099908 Priority application(s): WO2008/099908

5 November 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Sep 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215434-Pest control using lysozyme, salt or biological fragment thereof or lysozyme-related peptide as egg recognition pheromone

2008215431-Therapeutic agent for urinary excretion disorder